Medicines Act Notices




NEW ZEALAND GAZETTE

No. 169


Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Orciprenaline sulphate 0.75 mg per dose Spray, oral, metered dose Boehringer Ingelheim KG., Ingelheim am Rhein, Germany Alupent Inhaler
Ciprofloxacin hydrochloride 58.22 mg/mL, 116.44 mg/mL equivalent to 50 mg/mL, 100 mg/mL ciprofloxacin and diluent Microcapsules for suspension Bayer AG., Leverkusen, Germany Ciproxin Suspension
Dalteparin sodium 10,000 IU in 1 mL, 4 mL Injection, ampoule Pharmacia & Upjohn, Stockholm, Sweden Fragmin
Dalteparin sodium 2,500 IU in 0.2 mL, 25,000 IU/mL in 0.2 mL, 0.4 mL, 0.5 mL, 0.6 mL, 0.72 mL Injection, prefilled syringe Pharmacia & Upjohn, Stockholm, Sweden Fragmin
Dalteparin sodium 10,000 IU in 1 mL, 4 mL Injection, ampoule Pharmacia & Upjohn, Stockholm, Sweden Fragmin
Dalteparin sodium 2,500 IU in 0.2 mL, 25,000 IU/mL in 0.2 mL, 0.4 mL, 0.5 mL, 0.6 mL, 0.72 mL Injection, prefilled syringe Pharmacia & Upjohn, Stockholm, Sweden Fragmin
Lenograstim 13.4 MIU Injection, powder, vial Chugai Pharmaceutical Co Limited, Utsonomiya, Tochigi, Japan Granocyte 13
Lenograstim 33.6 MIU Injection, powder, vial Chugai Pharmaceutical Co Limited, Utsonomiya, Tochigi, Japan Granocyte 34
Human chorionic gonadotrophin 500 IU, 1500 IU, 5000 IU; sodium chloride as diluent Injection, powder for, ampoule; Diluent, ampoule Organon International BV., Oss, The Netherlands Pregnyl
Finasteride 1 mg Tablet, film coated Merck Sharp & Dohme Limited, Hoddesdon, Hertfordshire, England; Merck Sharp & Dohme Limited, Cramlington, Northumberland, England and Merck Sharp & Dohme (Australia) Pty Limited, South Granville, New South Wales, Australia Propecia
Epoetin beta 1000 IU, 2000 IU, 5000 IU, 10,000 IU equivalent to 8.3 µg, 16.6 µg, 41.5 µg and 83 µg epoetin; and water for injections as diluent Injection, powder for, vial; Diluent, ampoule Boehringer Mannheim GmbH., Mannheim, Germany Recormon
Vigabatrin 500 mg, 1 g Powder, oral, sachet Marion Merrell Dow France SA., Bourgoin-Jallieu Cedex, France Sabril

Dated this 30th day of November 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.

go8802


Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1997, No 169


NZLII PDF NZ Gazette 1997, No 169





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
30 November 1997
Medicines Act, Distribution Consent, Changed Medicines, Pharmaceuticals
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
Medicines Act, Provisional Consent, New Medicine, Pharmaceuticals